MC2278A1 - Nouveaux derives puriques - Google Patents

Nouveaux derives puriques

Info

Publication number
MC2278A1
MC2278A1 MC912204A MC2204A MC2278A1 MC 2278 A1 MC2278 A1 MC 2278A1 MC 912204 A MC912204 A MC 912204A MC 2204 A MC2204 A MC 2204A MC 2278 A1 MC2278 A1 MC 2278A1
Authority
MC
Monaco
Prior art keywords
purical
derivatives
new
purical derivatives
new purical
Prior art date
Application number
MC912204A
Other languages
English (en)
Inventor
Jaunin Roland
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2278A1 publication Critical patent/MC2278A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
MC912204A 1990-07-18 1991-07-11 Nouveaux derives puriques MC2278A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH238790 1990-07-18

Publications (1)

Publication Number Publication Date
MC2278A1 true MC2278A1 (fr) 1993-06-23

Family

ID=4232597

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912204A MC2278A1 (fr) 1990-07-18 1991-07-11 Nouveaux derives puriques

Country Status (13)

Country Link
EP (1) EP0467207A3 (fr)
JP (1) JPH04234391A (fr)
KR (1) KR920002600A (fr)
AU (1) AU8038491A (fr)
CA (1) CA2044806A1 (fr)
FI (1) FI913407A (fr)
HU (1) HU209591B (fr)
IE (1) IE912500A1 (fr)
IL (1) IL98812A0 (fr)
MC (1) MC2278A1 (fr)
NO (1) NO912804L (fr)
PT (1) PT98348A (fr)
ZA (1) ZA915418B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5202328A (en) * 1991-03-06 1993-04-13 Merck & Co., Inc. Substituted fused pyrimidinones
TW274551B (fr) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
PE20030008A1 (es) 2001-06-19 2003-01-22 Bristol Myers Squibb Co Inhibidores duales de pde 7 y pde 4
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (fr) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (fr) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (fr) * 1986-07-11 1995-01-24 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use

Also Published As

Publication number Publication date
HUT58736A (en) 1992-03-30
IE912500A1 (en) 1992-01-29
KR920002600A (ko) 1992-02-28
NO912804L (no) 1992-01-20
HU912347D0 (en) 1991-12-30
PT98348A (pt) 1992-05-29
FI913407A0 (fi) 1991-07-15
NO912804D0 (no) 1991-07-17
FI913407A (fi) 1992-01-19
CA2044806A1 (fr) 1992-01-19
ZA915418B (en) 1992-03-25
HU209591B (en) 1994-08-29
EP0467207A2 (fr) 1992-01-22
IL98812A0 (en) 1992-07-15
EP0467207A3 (en) 1992-08-12
JPH04234391A (ja) 1992-08-24
AU8038491A (en) 1992-01-23

Similar Documents

Publication Publication Date Title
DE69119329D1 (de) Actinonin-Derivate
MA22729A1 (fr) Nouveaux derives de peptide
FI925523A (fi) Hydroxi- och alkoxipyridinderivat
FI932809A0 (fi) Kaernreaktoranlaeggning med en kaernspaerranordning och foerfarande foer avkylning av densamma i naturligt kretslopp
DE69208877D1 (de) Chinuclidinderivate
FI931357A (fi) Framstaellning av polyhydroxifettsyraamider i naervaro av loesningsmedel
NO922182L (no) Krystallinske oksatiolan-derivater
MA22407A1 (fr) Steroides-esters nouveaux
DE69125099D1 (de) Indolderivate
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
FI925763A (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
DE69130255T2 (de) Oxadolderivate
DK0472733T3 (da) Phenantrenderivater
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
MC2278A1 (fr) Nouveaux derives puriques
FR2727680B1 (fr) Nouveaux derives de 5-pyrrolyl-6-halogeno-2- pyridylmethylsufinylbenzimidazole
MA23563A1 (fr) Nouveaux derives dialkoxy - pyridinyle - benzimidazole
FI923779A (fi) Foerbaettringar i tillverkningen av nylongarn
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
BR9104543A (pt) Derivados de triazolpiridazina
MC2225A1 (fr) Derives de diamine
DE69211197T2 (de) 1-Hydroxyvitamin D-Derivate
KR930702353A (ko) 2- 카르바페넴 유도체
FR2621590B1 (fr) Nouveaux derives du mercurobutol
FI930123A0 (fi) Foerfarande foer anvaendning av oxiderade lipoproteiner i virusartade infektioner